Get all your news in one place.

100’s of premium titles.
One app.

Get all your news in one place.

100’s of premium titles. One news app.

The Latest Breaking News from HTG Molecular Diagnostics

12 Health Care Stocks Moving In Friday's Intraday Session

5 Short Squeeze Candidates To Watch This Week: Singing Machine And Revlon Top The List, Chicken Soup For Soul Rejoins

5 Short Squeeze Candidates To Watch This Week: Singing Machine And Revlon Top The List, Chicken Soup For Soul Rejoins

Potential short squeeze plays gained steam in 2021, with new retail traders looking for the next huge move.

HTG Molecular Diagnostics's Return On Capital Employed Insights

HTG Molecular Diagnostics's Return On Capital Employed Insights

HTG Molecular Diagnostics (NASDAQ:HTGM) brought in sales totaling $1.18 million during Q1 according to data provided by Benzinga Pro. However, earnings decreased 25.16%, resulting in a loss of $6.50 million.

From analysis to the latest developments in health,
read the most diverse news in one place.

inkl

12 Health Care Stocks Moving In Tuesday's After-Market Session

Recap: HTG Molecular Diagnostics Q1 Earnings

HTG Molecular Diagnostics (NASDAQ:HTGM) reported its Q1 earnings results on Thursday, May 12, 2022 at 04:00 PM. Here's what investors need to know about the announcement.

Earnings Outlook For HTG Molecular Diagnostics

HTG Molecular Diagnostics (NASDAQ:HTGM) is set to give its latest quarterly earnings report on Thursday, 2022-05-12. Here's what investors need to know before the announcement. Analysts estimate that HTG Molecular Diagnostics will report an earnings per share (EPS) of $-0.71.

12 Health Care Stocks Moving In Wednesday's After-Market Session

inkl

Read news from The Economist, FT, and more,
with one subscription

Looking Into HTG Molecular Diagnostics's Return On Capital Employed

Looking Into HTG Molecular Diagnostics's Return On Capital Employed

HTG Molecular Diagnostics (NASDAQ:HTGM) brought in sales totaling $2.88 million during Q4 according to data provided by Benzinga Pro. However, earnings decreased 15.6%, resulting in a loss of $5.19 million.

Earnings Preview: HTG Molecular Diagnostics

Earnings Preview: HTG Molecular Diagnostics

HTG Molecular Diagnostics (NASDAQ:HTGM) is set to give its latest quarterly earnings report on Tuesday, 2022-03-29. Here's what investors need to know before the announcement. Analysts estimate that HTG Molecular Diagnostics will report an earnings per share (EPS) of $-0.59.

Stocks That Hit 52-Week Lows On Thursday

Stocks That Hit 52-Week Lows On Thursday

On Thursday, 112 stocks made new 52-week lows.

Organisations

Stanley Black Decker

Cross Country Healthcare

Blackrock Muniholdings

Enveric Biosciences

Genocea Biosciences

HTG Molecular Diagnostics

VistaGen rapeutics

From analysis to the latest developments in health,
read the most diverse news in one place.

inkl

Topics

inkl

Read news from The Economist, FT, and more,
with one subscription

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.

Download on the AppStore

Get it on Google Play